ReNeuron Group
高管
查看带有其 5 名主要高管的组织结构图
ReNeuron Group 搜索最多的简介
- Mike Owen, Non Executive Director
- Martin Walton, Non-Executive Director
- Barbara Staehelin, Senior Independent Director
高管在ReNeuron Group变化
- John Hawkins, Chief Financial Officer and Director, 将于 20245月7 退休 (新闻发布的2024四月22号).
创建提醒
跟踪 ReNeuron Group 的高管变动
药店
ReNeuron Group 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
ReNeuron Group 的最新新闻稿
- Company restructuring update - ReNeuron
- Directorate Change - ReNeuron
- Positive induced pluripotent stem cell data presented at industry conference - ReNeuron
- Interim Results for the six months ended 30 September 2022 - ReNeuron
- Positive Exosome Data Presented at US Conference - ReNeuron
- Directorate and Executive Changes - Appointment of Chief Financial Officer and Chief Business Officer - ReNeuron
- Result of AGM - ReNeuron
- Posting of Annual Report & Accounts & Notice of AGM - ReNeuron
- Directorate Change - Catherine Isted appointed as Chief Executive Officer - ReNeuron
- Preliminary Results for the year ended 31 March 2022 - ReNeuron
- View more press releases Close
通过电子邮件
